Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Eli Lilly and Company LLY

Healthcare  —  Drug Manufacturers General
1,183.46 1.57 0.13% as of 25 Sep
Market cap
$1.11T
P/E
39.7×
S&P 500 Member Dividend Aristocrat Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Eli Lilly and Company (LLY) Price to free cash flow

As of 25 September 2026, Eli Lilly and Company (LLY) trades at a price to free cash flow of 51.8×. Over the past ten years it has ranged from 15.8× (February 2018) to 518× (June 2024); the current reading is higher than 70% of that period. That is above the Drug Manufacturers General industry median of 17.7× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 86.3× (26.00%)
FY2024 117× (46.13%)
FY2023 217× 281.38%
FY2022 56.8× 46.53%
FY2021 38.7× 39.60%
FY2020 27.8× (4.46%)
FY2019 29.0× 15.38%
FY2018 25.2× 39.85%
FY2017 18.0× (2.02%)
FY2016 18.4× (50.70%)

Quarterly

Period Price to free cash flow Change
Jun 2026 52.5× (10.52%)
Mar 2026 58.7× (32.03%)
Dec 2025 86.3× 44.69%
Sep 2025 59.6× (39.61%)
42 more quarters

Against its own ten years

Low 15.8× High 518×
Ten-year median 33.9×
Current reading's percentile 70

Price to free cash flow against peers

Company Price to free cash flow
GILD Gilead Sciences, Inc. compare 14.5×
PFE Pfizer Inc. compare 16.0×
NVS Novartis AG compare 18.3×
MRK Merck & Co., Inc. compare 22.9×
AMGN Amgen Inc. compare 23.0×
ABBV AbbVie Inc. compare 25.7×
JNJ Johnson & Johnson compare 28.7×
AZN AstraZeneca PLC compare 41.2×
LLY Eli Lilly and Company 51.8×
Drug Manufacturers General industry median 17.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on LLY